Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In a nationwide retrospective observational study of 227,571 Medicare beneficiaries aged 65 years or older, it was found that 2,593 of the 67,593 patients using rosiglitazone and 5,386 of the 159,978 using pioglitazone had serious cardiovascular problems. These data are summarized in the contingency table below. Cardiovascular problems Yes No Total Rosiglitazone 2,593 65,000 Pioglitazone 5,386| 154,592 159,978 7,979 219,592 227,571 67,593 Total a) Write a set of hypotheses comparing the rates for cardiovascular problems for the two treatments. Но: р, — рp ? HA: Pr – Pp ? v b) Compute the point estimate, the observed difference in rates for cardiovascular problems in the two treatments. P, - P = %3D р. (1 — р.) P„(1 – ê,) c) Compute the standard error. (SE = with n, = number in the Пр Rosiglitazone group and n, = number in the Pioglitazone group.) The standard error is d) Using the point estimate and standard error above, compute the test statistic and two-sided p-value. The test statistic is The p-value O The p-value < .001 (Choose p < .001 for small p-values.) e) Write a suitable conclusion based on your p-value.

MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
icon
Related questions
Question
Tan/ page
Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been
linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A
common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In
a nationwide retrospective observational study of 227,571 Medicare beneficiaries aged 65 years or older, it
was found that 2,593 of the 67,593 patients using rosiglitazone and 5,386 of the 159,978 using pioglitazone
had serious cardiovascular problems. These data are summarized in the contingency table below.
Cardiovascular problems
Yes
No
Total
Rosiglitazone 2,593 65,000
Pioglitazone 5,386 154,592 159,978
67,593
Total
7,979 219,592 227,571
a) Write a set of hypotheses comparing the rates for cardiovascular problems for the two treatments.
Но: р, — рp?
На: р, — Рp ?
Compute the point estimate, the observed difference in rates for cardiovascular problems in the two
treatments.
P, - Pp =
р, (1 — р,)
Pp(1 – P,)
c) Compute the standard error. (SE =
with n, = number in the
Пр
Rosiglitazone group and np = number in the Pioglitazone group.)
The standard error is
d) Using the point estimate and standard error above, compute the test statistic and two-sided p-value.
The test statistic is
O The p-value
The p-value < .001
(Choose p < .001 for small p-values.)
e) Write a suitable conclusion based on your p-value.
JWe cheuldlceloet on on wer
the puIl bunethecic
There
ISeleet en onewe
lencethat
Transcribed Image Text:Tan/ page Rosiglitazone is the active ingredient in the controversial type 2 diabetes medicine Avandia and has been linked to an increased risk of serious cardiovascular problems such as stroke, heart failure, and death. A common alternative treatment is pioglitazone, the active ingredient in a diabetes medicine called Actos. In a nationwide retrospective observational study of 227,571 Medicare beneficiaries aged 65 years or older, it was found that 2,593 of the 67,593 patients using rosiglitazone and 5,386 of the 159,978 using pioglitazone had serious cardiovascular problems. These data are summarized in the contingency table below. Cardiovascular problems Yes No Total Rosiglitazone 2,593 65,000 Pioglitazone 5,386 154,592 159,978 67,593 Total 7,979 219,592 227,571 a) Write a set of hypotheses comparing the rates for cardiovascular problems for the two treatments. Но: р, — рp? На: р, — Рp ? Compute the point estimate, the observed difference in rates for cardiovascular problems in the two treatments. P, - Pp = р, (1 — р,) Pp(1 – P,) c) Compute the standard error. (SE = with n, = number in the Пр Rosiglitazone group and np = number in the Pioglitazone group.) The standard error is d) Using the point estimate and standard error above, compute the test statistic and two-sided p-value. The test statistic is O The p-value The p-value < .001 (Choose p < .001 for small p-values.) e) Write a suitable conclusion based on your p-value. JWe cheuldlceloet on on wer the puIl bunethecic There ISeleet en onewe lencethat
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Similar questions
Recommended textbooks for you
MATLAB: An Introduction with Applications
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman